CJC-1295 (No DAC)

$30
CJC-1295 (No DAC): 10MG
118 pieces in stock

CJC1295 No DAC Overview

CJC1295 no DAC is a synthetic growth hormone-releasing hormone (GHRH) analog, which can effectively stimulate growth hormone secretion, promote muscle growth and repair, regulate fat metabolism, and enhance bone density. These effects make it play an important role in the study of the mechanism of growth hormone secretion, the treatment of growth hormone-related diseases (e.g., growth hormone deficiency, dwarfism, etc.), as well as the exploration of new drug targets and therapeutic approaches. In addition, as we age, the level of growth hormone in our bodies gradually decreases, leading to aging phenomena such as muscle loss, fat gain, and skin laxity, etc. CJC1295 no DAC is able to increase the level of growth hormone, which is potentially anti-aging, and can be used to study ways to slow down the aging process and improve the quality of life of the elderly. In the field of sports, CJC1295 no DAC can promote muscle growth and repair, enhance athletic performance, and improve athletes' performance and competitiveness, so it has attracted attention among athletes.


Peptide Information

Property Value
Peptide Sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Molecular Formula C152H252N44O42
Molecular Weight 3367.9 g/mol
CAS Number 4446262-90-4
PubChem CID 91976842
Synonyms Mod GRF (1-29), CJC-1295 no DAC 


CJC1295 No DAC Research

What is the research background of CJC1295 no DAC?

Growth hormone-releasing hormone (GHRH) is used in treatment to enhance the secretion of growth hormone (GH), but it has a major limitation, that is, its short duration of action[1]. This limits the widespread clinical application of GHRH and prompts researchers to seek more long-acting alternatives. CJC1295 no DAC is a peptide drug based on 30 amino acids. It can stimulate the pituitary gland to release growth hormone (GH). This peptide drug is different from traditional peptide drugs. Its uniqueness lies in the presence of a reactive maleimide propionic acid group, which can covalently bind to the free thiols on the surface of plasma proteins. Once bound to plasma proteins, the active time of CJC1295 no DAC in the blood is significantly prolonged. Compared with unbound peptide drugs, those unbound peptide drugs will be rapidly excreted from the body, while the bound CJC1295 no DAC can remain active in the blood for a longer time. This binding mechanism makes CJC1295 no DAC a drug with a special effect.

What is the mechanism of action of CJC1295 no DAC?

Stimulating the pituitary gland to release growth hormone: This drug can stimulate the pituitary gland to release growth hormone (GH). When CJC1295 no DAC enters the body, it acts on the pituitary gland through a specific mechanism, prompting pituitary cells to increase the secretion of GH. Specifically, it may bind to specific receptors on the surface of pituitary cells, initiating a series of signal transduction pathways, ultimately leading to an increase in the synthesis and release of GH [1, 2].

Binding to plasma proteins: CJC1295 no DAC has a unique feature, that is, there is a reactive group in its structure, which can covalently bind to the free thiols on the surface of plasma proteins. This binding significantly prolongs the time that the drug remains active in the blood. Compared with unbound peptide drugs, the bound CJC1295 no DAC has a longer half-life [2]. Some studies have shown that CJC-1295 incorporates a functional maleimide group at the C-terminus, allowing it to covalently bind to plasma proteins such as serum albumin. Once bound, it can stimulate GH production in humans for more than six days after a single administration (Timms M, 2019, a).

Increasing the secretion of growth hormone: After a single injection of CJC1295 no DAC, it will lead to a dose-dependent increase in the average plasma GH concentration. This increase can last for 6 days or longer, with an increase range of 2 to 10 times [2-4]. In a study, after healthy adults received a subcutaneous injection of CJC-1295, there was a continuous, dose-dependent increase in GH levels. The estimated half-life of CJC-1295 was 5.8 - 8.1 days (Teichman S L, 2006). In GHRH knockout (GHRHKO) mice, similar properties were also shown. Daily administration of CJC1295 can maintain normal body composition and growth[5].

Affecting the secretion of insulin-like growth factor I: CJC1295 no DAC will also affect the secretion of insulin-like growth factor I (IGF-I). The average plasma IGF-I concentration will increase in a dose-dependent manner, with an increase range of 1.5 to 3 times, and the duration is 9 - 11 days [2-4]. After multiple administrations of the CJC1295 no DAC dose, the average IGF-I level remains higher than the baseline level for up to 28 days (Teichman S L, 2006). In GHRHKO mice, CJC1295 also caused an increase in total pituitary RNA and GH mRNA, indicating the proliferation of growth hormone-secreting cells[5].

Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor  I Secretion by CJC-1295, a Long-Acting Analog of GH-

 

Plasma disappearance curves of CJC-1295 after a single sc injection. Shown are the mean SD half-life.

Source:PubMed[1]

What are the differences in the treatment mechanisms of CJC1295 no DAC for patients with growth hormone deficiency of different age groups?

Child patients: Children are in a critical period of growth and development, and growth hormone plays a crucial role in the growth and development of their bones, muscles, and organs. Growth hormone deficiency can lead to problems such as slow growth, short stature, and delayed bone age in children.

CJC1295 no DAC promotes the growth and development of children by stimulating the pituitary gland to secrete growth hormone. It can increase the secretion amount and duration of growth hormone, and raise the levels of growth hormone and insulin-like growth factor - I (IGF-I) in the serum[3]. IGF-I is the main mediator of the action of growth hormone. It can promote cell proliferation, differentiation, and protein synthesis, and has an important role in the growth and development of bones, muscles, and organs. CJC1295 no DAC can also promote the increase of bone metabolism indicators such as osteocalcin and alkaline phosphatase, which is helpful for the growth and mineralization of bones. In addition, CJC1295 no DAC has no obvious effect on thyroid function and has a high safety level.

Adult patients: 

Adult patients with growth hormone deficiency may experience problems such as decreased muscle mass, increased fat, decreased physical strength, increased risk of cardiovascular diseases, and osteoporosis. Compared with child patients, the growth and development of adult patients have been basically completed, and the focus of treatment is on improving metabolic function and quality of life. The treatment mechanism of CJC1295 no DAC in adult patients is mainly to improve muscle strength, reduce fat mass, improve heart function, delay aging, and prevent osteoporosis by increasing the levels of growth hormone and IGF-I. Studies have shown that CJC1295 no DAC can increase the lean body mass of adult patients, reduce subcutaneous fat mass, improve insulin sensitivity, and reduce the risk of cardiovascular diseases. In addition, CJC1295 no DAC can also promote the growth and mineralization of bones, increase bone density, and prevent osteoporosis [3, 5].

Elderly patients: 

With the increase of age, the secretion of growth hormone in the human body gradually decreases, leading to problems such as decreased muscle mass, increased fat, osteoporosis, and decreased immunity. Elderly patients with growth hormone deficiency have a higher disease risk, and the treatment is more difficult. The treatment mechanism of CJC1295 no DAC in elderly patients is similar to that in adult patients, but the dosage needs to be adjusted more carefully and adverse reactions need to be monitored. Due to the decline of the physical functions of elderly patients and the weakened ability to metabolize and excrete drugs, the dosage of the drug needs to be reduced to avoid drug accumulation and the occurrence of adverse reactions.

Related research

What are the effects of CJC1295 no DAC?

Promoting the secretion of growth hormone: 

As an analogue of growth hormone-releasing hormone (GHRH), CJC1295 no DAC can bind to the GHRH receptors in the anterior pituitary gland and stimulate the synthesis and secretion of growth hormone by growth hormone cells. Growth hormone is crucial for the body's growth and development, metabolism, and tissue repair processes. In some studies, after using CJC1295 no DAC, an increase in the level of growth hormone in the blood can be observed, which helps to promote the growth and repair of tissues such as bones and muscles.

Regulating metabolism: 

Growth hormone plays a key role in the regulation of metabolism. CJC1295 no DAC indirectly affects the metabolic process by promoting the secretion of growth hormone. It can promote fat breakdown, making fat be used as an energy source, which helps to reduce the storage of fat in the body and improve the body's fat distribution. At the same time, it can also promote protein synthesis, increase the deposition of protein in muscle tissues, which helps to improve muscle quality and strength, and enhance the body's exercise ability and endurance. In addition, CJC1295 no DAC also has a certain impact on glucose metabolism, and may increase insulin sensitivity, which helps to maintain normal blood glucose levels.

Promoting tissue repair and regeneration: 

Growth hormone plays an important role in the repair and regeneration of damaged tissues. CJC1295 no DAC promotes the secretion of growth hormone, which in turn stimulates cell proliferation and differentiation, accelerates wound healing, and promotes the repair of damaged tissues. In some animal experiments and clinical studies, it has been found that it is helpful for fracture healing, muscle injury repair, and skin wound healing, etc., and has potential significance for improving the body's recovery ability and restoring the function of damaged tissues.

What are the application fields of CJC1295 no DAC?

Treatment of growth hormone deficiency: 

For patients with growth hormone deficiency, CJC-1295 Without DAC can stimulate the secretion of growth hormone, thus promoting the growth and development of the body. It may provide a new treatment option for those patients who have poor response to traditional growth hormone treatment[3].

Regulation of metabolic disorders: 

Growth hormone plays an important role in regulating the body's metabolic process. CJC-1295 Without DAC can improve insulin resistance, regulate fat metabolism, etc. by increasing the secretion of growth hormone, and may have certain therapeutic potential for metabolic disorders such as diabetes and obesity[3].

Skin rejuvenation: 

Growth hormone can promote the synthesis of collagen, increase skin elasticity, and reduce wrinkles. CJC-1295 Without DAC may achieve skin rejuvenation by stimulating the secretion of growth hormone[6].

Improving physical function: 

With the increase of age, various functions of the body will gradually decline. Growth hormone can increase muscle strength, improve bone density, and enhance immunity, etc. CJC-1295 Without DAC may help to delay the aging process and improve the quality of life of the elderly[3].

Increasing muscle strength: 

Growth hormone can promote protein synthesis and increase muscle mass. For athletes and fitness enthusiasts, CJC-1295 Without DAC may help to improve muscle strength and endurance[6].

Promoting exercise recovery: 

After high-intensity exercise, the body needs time to recover. Growth hormone can accelerate the repair of damaged tissues and reduce the inflammatory response. CJC-1295 Without DAC may help to shorten the recovery time after exercise and improve exercise performance [3].

Anti-aging: 

With the increasing attention to anti-aging, CJC1295 no DAC is also considered by some people to have the potential of anti-aging. Growth hormone and IGF-I play an important role in maintaining the normal physiological functions of the body and tissue repair. Therefore, this substance may have an impact on the aging process by regulating these factors [3].

As an analogue of growth hormone-releasing hormone, CJC1295 no DAC has significant effects. It can stimulate the pituitary gland to release growth hormone, regulate the secretion of insulin-like growth factor I, and thus affect the growth and metabolism of the body. In scientific research, it provides key assistance for exploring the mechanism of action of growth hormone and promotes the progress of relevant theories. In clinical applications, for patients with growth hormone deficiency, it is expected to stimulate the secretion of endogenous growth hormone and improve growth and development and metabolic abnormalities. It also shows the potential to regulate hormone levels and combat aging changes in anti-aging research. Overall, it is of great significance in both scientific research and clinical fields, bringing new opportunities for related research and disease treatment.

Relevant Citations

[1] Teichman S L, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults[J]. Journal of Clinical Endocrinology & Metabolism, 2006,91(3):799-805.DOI:10.1210/jc.2005-1536.

[2] Timms M, Ganio K, Steel R. A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS[J]. Drug Testing and Analysis, 2019,11(8):1248-1257.DOI:10.1002/dta.2599.

[3] Teichman S L, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults[J]. Journal of Clinical Endocrinology & Metabolism, 2006,91(3):799-805.DOI:10.1210/jc.2005-1536.

[4] Timms M, Ganio K, Forbes G, et al. An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma[J]. Drug Testing and Analysis, 2019,11(6):804-812.DOI:10.1002/dta.2554.

[5] Alba M, Fintini D, Sagazio A, et al. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse[J]. American Journal of Physiology-Endocrinology and Metabolism, 2006,291(6):E1290-E1294.DOI:10.1152/ajpendo.00201.2006.

[6] Van Hout M C, Hearne E. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions[J]. Substance Use & Misuse, 2016,51(1):73-84.DOI:10.3109/10826084.2015.1082595.

For Research Use Only
This compound is provided exclusively for in vitro laboratory research. It is not intended for human or animal consumption, diagnosis, treatment, or medical use. Not for dietary, cosmetic, or veterinary purposes. This product has not been evaluated by the U.S. Food and Drug Administration or any other regulatory authority.


Disclaimer
All information is for educational purposes only. Humatide makes no claims regarding efficacy or safety. Purchasers are responsible for ensuring proper handling and use in compliance with all applicable laws and regulations.


Terms of Sale
By purchasing from Humatide, you confirm that you are a qualified researcher with the knowledge and facilities to safely handle and store research chemicals. All sales are final. Humatide assumes no liability for misuse, misrepresentation, or unintended consequences arising from the use of this product.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.


Polypeptide Purity Control and Verification Technical System

Humatide.com provides peptides with purity exceeding 99%. Humatide achieves precise control and scientific verification of polypeptide purity by integrating advanced technologies and a full-process quality control system: In the synthesis stage, automated solid-phase peptide synthesis (SPPS) is employed to accurately assemble amino acid sequences. A gradient purification strategy ranging from medium-pressure liquid chromatography (MPLC) to preparative high-performance liquid chromatography (Prep-HPLC) is utilized, optimizing mobile phase composition and elution conditions based on the physicochemical properties of the target peptide (hydrophobicity, charge distribution, etc.) to efficiently remove impurities. For purity detection, reverse-phase high-performance liquid chromatography (RP-HPLC) serves as the core technique, separating components through the distribution difference of molecules between the stationary phase (hydrophobic packing) and the mobile phase (polar solvent). Purity is determined via retention time matching and peak area normalization. Meanwhile, electrospray ionization mass spectrometry (ESI-MS) is combined to precisely verify the molecular weight and composition through mass-to-charge ratio (m/z) analysis, eliminating structurally heterogeneous impurities. Quality management covers the entire chain from raw material acceptance, synthesis process monitoring to finished product release. A continuous quality fingerprint is constructed using multi-dimensional indicators (HPLC purity, MS molecular weight, solvent residue, etc.), and batch data traceability is achieved through a laboratory information management system (LIMS), ensuring each batch meets the prespecified purity standards. This system provides a reliable technical guarantee for preparing high-purity polypeptides through the organic integration of process optimization, multi-dimensional detection, and full-process quality control.


Concepts of High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)

High-performance liquid chromatography (HPLC) is a separation technology widely used by Humatide for peptide purification. Driven by a high-pressure pump, the mobile phase carries samples through a chromatographic column packed with a specific stationary phase, achieving separation based on differences in the distribution coefficients of components between the two phases. It features high separation efficiency, fast analysis speed, and strong detection sensitivity, enabling precise capture of subtle differences between target peptides and impurities such as sequence analogs or deletion peptides.

Mass spectrometry (MS) is an analytical method that converts peptide molecules into gas-phase ions through ionization technology and separates/detects ions based on their mass-to-charge ratio (m/z). It can accurately determine the molecular weight of peptides and infer amino acid sequences through fragment ion information, serving as a key technology for verifying peptide structural correctness. The combination of these two techniques allows Humatide to establish a complete quality control system from both purity separation and structural confirmation perspectives. Both methods are high-precision peptide detection technologies that scientifically demonstrate the purity and composition of peptides ordered from Humatide.com.

Humatide is committed to translating cutting-edge analytical technologies into tangible quality assurance. Our peptide synthesis laboratories are equipped with high-resolution mass spectrometers and ultra-high-performance liquid chromatography systems. Through real-time detection and data comparison of samples at each production stage, we continuously optimize synthesis processes to ensure every peptide product is delivered to customers with exceptional purity.


Recommended Peptide Purity Levels

Humatide provides only the highest-purity peptides (purity ≥99%) for research and development. The minimum recommended peptide purity level for specific applications depends on the application:

• In biochemical research, peptides used for enzyme activity analysis typically require ≥85% purity.

• In drug development, peptides for preclinical trials must meet >98% high-purity standards to ensure biological activity and safety.

• For diagnostic applications (e.g., antigen peptides in immunoassays), recommended purity is 90%-95% to guarantee detection specificity and sensitivity.

Humatide is confident in the quality of all our products, implementing strict quality monitoring at every stage of peptide synthesis—from crude peptide purification to final product release. Through multi-step purification and verification processes, we ensure each batch meets or exceeds the purity requirements for specific applications. Examples of acceptable minimum purity levels are as follows:


High Purity (>95%)

• Polypeptide drug research and production

• Preparation of targeted therapeutic drugs

• Raw materials for biological diagnostic reagents (e.g., ELISA, immunoassay kits)

• Development of polypeptide vaccines (therapeutic/preventive)

• Preparation of targeting peptides for antibody-drug conjugates (ADCs)

• Polypeptide reagents for life science research (e.g., receptor agonists/antagonists)

• Research on targeting peptide modification for gene therapy vectors

• Development of polypeptide antibiotics/antimicrobial peptides

• Preparation of polypeptide hormone analogs (e.g., insulin analogs)

• Reference standards for biomarker detection

• Research on cell culture additives

• Synthetic peptides for protein structure analysis and functional studies


Moderate Purity (>85%)

• Early-stage activity screening in polypeptide drug research

• Peptide additives for industrial enzymes

• Signal peptide raw materials

• Surface modification of biomaterials (e.g., medical catheters, tissue engineering scaffolds)

• Preparation of agricultural antimicrobial peptides

• Cell adhesion research

• Raw materials for polypeptide surfactants/detergents

• Polypeptide reagents for preliminary mechanistic research in scientific studies


Lower Purity (>70%)

• Preliminary structure-activity relationship (SAR) studies

• Initial verification of protein binding

• Primary cytotoxicity screening

• High-throughput screening of polypeptide drug lead compounds


Please note

**We are not responsible for reconstitution or any issue that arise from it**



High-purity polypeptides are suitable for scenarios requiring strict purity. The ultra-high-purity peptides provided by Humatide can meet and exceed all prespecified purity standards.

Humatide Shipping & Delivery

Shipping Methods & Delivery Times

Standard handling is 24 hours excluding Holidays and Weekends

International Shipping – Not available at this time.

The explained transit time are not guaranteed.  Humatide is not responsible nor will refunds be given due to transit delays.

Order Tracking

Once your order has shipped, you’ll receive an email with a tracking number and link.
If you experience any tracking issues, reach out to us at help@humatide.com.

Shipping Issues

If your order arrives damaged, incorrect, or incomplete, contact us within 48 hours of delivery at help@humatide.com.  Please have photos available to expedite inquires.  We’ll make it right with a replacement or refund.

Carrier Delays

Humatide is not responsible for delivery delays caused by:

  • Severe weather
  • Carrier errors
  • Events outside our control
  • Extended transit times in rural areas
  • Holidays

Address Accuracy

Please double-check your shipping address during checkout.
We are not responsible for orders delayed or lost due to incomplete or incorrect addresses.

Delivery Confirmation

If tracking shows your package as delivered but you haven’t received it:

Contact UPS directly.

We’re happy to assist with a carrier claim, but Humatide is not liable for lost or stolen packages after confirmed delivery.

Returns & Exchanges

Refund Policy
Due to the sensitive nature of research products, all sales are final.
We cannot accept returns or issue refunds once an order has been shipped. This policy helps ensure product integrity and safety for all of our research partners.

Damaged or Defective Items

If your order is damaged and you declined shipping protection we can only provide you with up to $100 in store credit.  If you did select shipment protection we will replace any damaged good and ship out replacements at no cost.  If your order is incorrect, or missing items, please contact us within 48 hours of delivery so we can resolve the issue.  Please provide photos of the damaged items.

Lost or Stolen Shipments

If your order is lost or stolen and you declined shipping protection the maximum credit we can give you is $100 in store credit.  If you did select shipment protection we will replace the entire order if it's been lost at no charge if it is lost or stolen.  Please contact us within 48 hours of delivery so we can work with UPS to help resolve the issue.  

Final Sale Items

All sales are final and products are not eligible for return or exchange. 

Need Help?

We’re here to help.
Contact our support team anytime at help@humatide.com with any questions about shipping or returns.

To View the latest Certificate of Analysis (CoA) click the "View Latest 3rd Party Certificate of Analysis" button on the product page.  Please use that if you are looking to buy as that is the batch you'll receive if you place an order.  The QRCode will give you the Batch ID/Lot Number which is matched on the CoA to validate that CoA matches your specific vial.  If you happen to get a vial that is from a previous batch select the "Previous Batch 3rd Party Certificate of Analysis" if your Batch ID doesn't match the latest CoA.   

All CoA are searchable via the respective testers' website. 

ILS Labs Verification is available on their website at:  

https://ils-lab.com/verify

To validate the CoA on the ILS Labs website enter the Access Code that is located on the bottom of the CoA that is shown on our website.   

We also use MDx Biolabs, verification is available via their website at:  

https://mdxbiolabs.com/certificates-of-analysis

To find validate the CoA on the MDx Biolabs website enter the COA number which is located at the bottom of the CoA that is shown on our website.  

 

 

 

CJC-1295 (No DAC)
CJC-1295 (No DAC)
10MG
$30

Recently viewed